Searching journal content for acromegaly (as phrase) in full text.

Displaying results 1-10 of 117
For checked items
  1. ...acromegaly in the father, severe hypertension (possibly due to endocrine hypertension) in the brother who died at 39  years and MEN1-like features in the proband, who was a 48-year-old Caucasian female with a 3-cm 4i e . ( in . ( .I1 .I1 in ily l. lin l. i e . ( i e . ( i e . ( , a , f ili is , g , ~~~
  2. ...acromegaly V. The pathological finding in four autopsied cases of acromegaly with a discussion of their significance. Monograph. New York, NY, USA: Rockefeller Institute for Medical Research. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, L ~~~
  3. ...acromegaly caused by corticotroph and somatotroph adenomas, respectively. Pharmacological treatment of PIT depends on the type of hormone secretion. Treatment for prolactinomas is by dopamine agonists, whereas somatotroph adenomas can be medically treated by somatostatin analogs and the newer growth ~~~
  4. ...acromegaly and germline GPR101 microduplication or mutation occurs in patients with X-linked acrogigantism (X-LAG) (Vierimaa  et  al. 2006, Daly  et  al. 2007, Trivellin  et  al. 2014). Identification of a homozygous germline mutation in the cyclin-dependent kinase inhibitor (CDKI) gene CDKN1B/p27 i ~~~
  5. ...acromegaly at diagnosis 10.1530/ERC-17-0253 Patrick Petrossians1, Adrian F Daly1, Emil Natchev2, Luigi Maione3, Karin Blijdorp4, Mona Sahnoun-Fathallah5, Renata Auriemma6, Alpha M Diallo7, Anna-Lena Hulting8, Diego Ferone9, Vaclav Hana Jr10, Silvia Filipponi11, Caroline Sievers12, Claudia Nogueira13 ~~~
  6. ...acromegaly 10.1530/ERC-16-0553 Massimo Terzolo1, Giuseppe Reimondo1, Paola Bhialla2, Emanuele Ferrante3, Elena Malchiodi3, Laura De Marinis4, Rosario Pivonello5, Silvia Grottoli6, Marco Losa7, Salvatore Cannavo8, Diego Ferone9, Marcella Montini10, Marta Bondanelli11, Ernesto De Menis12, Chiara Marti ~~~
  7. ...acromegaly ~~~
  8. ...acromegaly associated with a novel deletion in CDKN1B 5′UTR region. Endocrine 49 58–64. (doi:10.1007/s12020-015-0540-y) Shi Z, Li Z, Li ZJ, Cheng K, Du Y, Fu H & Khuri FR 2015a Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3. Oncogene 34 2538–2545. (doi:10 ~~~
  9. ...acromegaly (Colao  et  al. 2014). Pegvisomant, a pegylated analogue of human GH, is currently the only GH-receptor antagonist approved by the FDA available for the treatment of acromegaly. It directly competes for receptor binding with plasma GH resulting in decreased IGF-1 production (van der Lely  ~~~
  10. ...acromegaly f hypoglycaemia R174Review G K Dimitriadis et al. Paraneoplastic syndromes DOI: 10.1530/ERC-17-0036 © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:6 amines or cytokines, or immune cross-reactivity between ne ~~~
For checked items